Mayne Pharma | Capitale Ordinario



Ordinary Share Capital Cambiamento Data
Ansell USD 1.03B 305.2M 2024-06
Cochlear AUD 1.18B 19.2M 2024-12
CSL USD 576M 19M 2024-12
Healius AUD 2.6B 100K 2024-12
Integral Diagnostics AUD 335.09M 1.07M 2024-06
Medical Developments International AUD 115.01M 9.28M 2024-12
Nanosonics AUD 114.74M 192K 2024-12
Next Science USD 133.93M 100.99K 2024-12
Polynovo AUD 191.6M 0 2024-06
Ramsay Health Care AUD 2.27B 19.6M 2024-12
ResMed USD 760K 2K 2024-12
Sigma Healthcare AUD 1.64B 43.99M 2024-07
Sonic Healthcare AUD 4.15B 467K 2024-12
Telix Pharmaceuticals AUD 587.41M 141.14M 2024-06



Mayne Pharma Capitale Ordinario - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Jun 2025.